| abstract |
The described invention relates to small molecule therapeutic compounds capable of reducing the incidence of intracerebral hemorrhage and brain microhemorrhages identified using zebrafish and mouse models of intracerebral hemorrhage and brain microhemorrhages, wherein said small molecule therapeutic compounds are selected from the group consisting of artemether and derivatives thereof (such as dihydroartemisinin, artemisinin, artesunate), benidipine, lacidipine, ethynylestradiol and triptolide. |